One of the first groups of AIDS patients to receive free HIV drugs in a public health setting in the developing world is living as long as those in the United States, according to research conducted by Weill Cornell Medicine investigators.
01 February 2016 | Weill Cornell Medical College
The proportion of people with HIV whose treatment is successful appears lower in the real world than in clinical trials, a researcher said here.
12 October 2015 | MedPage Today
The study, from the Canadian Observational Cohort Collaboration, indicated the overall life expectancy of Canadians undergoing antiretroviral treatment for the AIDS-causing virus had climbed to 65 years -- about a 16-year jump since 2000.
10 August 2015 | CTV News
People living with the HIV virus today can expect to live nearly two decades longer than those who were diagnosed at the start of this century, thanks to cheaper and more readily available antiretroviral drugs, the UN said in a major report on a disease once seen by many as a death sentence to be endured in secrecy. The average HIV-positive person is now expected to live for 55 years – 19 years longer than in 2001, according to the report by the UN’s Programme on HIV and AIDS (UNAids).
14 July 2015 | The Guardian
The AIDS targets of MDG 6—halting and reversing the spread of HIV—have been achieved and exceeded, according to a new report released today by the Joint United Nations Programme on HIV/AIDS (UNAIDS). New HIV infections have fallen by 35% and AIDS-related deaths by 41%. The global response to HIV has averted 30 million new HIV infections and nearly 8 million (7.8 million) AIDS-related deaths since 2000, when the MDGs were set.
14 July 2015 | UNAIDS
Long-term opioid use conferred a 40% higher death risk in a prospective study of U.S. veterans with or without HIV. The heightened risk ran to 46% in veterans with HIV compared with 25% in those without HIV. Long-term benzodiazepine use also inflated death risk in this population.
17 June 2015 | The Body
We found that PEPFAR was associated with a 13 percent increase in employment among males in focus nations compared to non-focus ones. In contrast, no change in employment was observed among females. In addition, we found that increasing PEPFAR per capita funding by $100 was associated with a 9.1-percentage-point average increase in employment among males.
15 June 2015 | Brookings Institution (blog)
Posirtive Lite editor Bob Leahy in conversation with CATIE’s Sean Hosein about START, the important and ground-breaking study that recently provided definitive evidence of the health benefits of starting HIV treatment sooner rather than later.
10 June 2015 | Positive Lite
Male HIV patients in rural South Africa reach the low immunity levels required to become eligible for antiretroviral treatment in less than half the time it takes for immunity levels to drop to similar levels in women, according to new research. Researchers also found a link between potential proxy measures of nutritional status and disease progression, with those reporting food shortages and use of nutritional supplements reaching lower levels of immunity faster.
10 June 2015 | Science Daily
Survival after the ﬁrst diagnosis of AIDS-opportunistic illness (OI) has markedly improved since 1981, but some AIDS-OIs still carry a much higher mortality risk than others, according to a survival analysis published online June 3 in the Journal of Infectious Diseases.
08 June 2015 | Medscape